EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-27.50%
2024-5.97%
202311.14%
202212.09%
20217.27%
202069.10%
2019587.77%
2018-60.72%
2017365.37%
2016-93.90%